Investigation of helenalin-induced cell death in Bcl-2 overexpressing Jurkat cells [Elektronische Ressource] / Ruth Hoffmann
96 pages
Deutsch

Découvre YouScribe en t'inscrivant gratuitement

Je m'inscris

Investigation of helenalin-induced cell death in Bcl-2 overexpressing Jurkat cells [Elektronische Ressource] / Ruth Hoffmann

Découvre YouScribe en t'inscrivant gratuitement

Je m'inscris
Obtenez un accès à la bibliothèque pour le consulter en ligne
En savoir plus
96 pages
Deutsch
Obtenez un accès à la bibliothèque pour le consulter en ligne
En savoir plus

Description

Dissertation zur Erlangung des Doktorgrades der Fakultät für Chemie und Pharmazie der Ludwig-Maximilians-Universität München Investigation of helenalin-induced cell death in Bcl-2 overexpressing Jurkat cells Ruth Hoffmann (geb. Meßmer) aus Spaichingen 2010 Erklärung Diese Dissertation wurde im Sinne von §13 Abs. 3 bzw. 4 der Promotionsordnung vom 29. Januar 1998 von Frau Prof. Dr. Angelika M. Vollmar am Lehrstuhl für Pharmazeutische Biologie betreut. Ehrenwörtliche Versicherung Diese Dissertation wurde selbstständig, ohne unerlaubte Hilfe erarbeitet. München, am 20.09.2010 Ruth Hoffmann (geb.Meßmer) Dissertation eingereicht am: 20.09.2010 1. Gutachter: Prof. Dr. Angelika M. Vollmar 2. Gutachter: PD Dr. Manfred Ogris Mündliche Prüfung am: 29.10.2010 CONTENTS 5 CONTENTS 6 CONTENTS 1 CONTENTS 1 CONTENTS..............................................................................................................6 2 INTRODUCTION ....................................................................................................10 2.1 Background and aim of the study ...........................................................................10 2.2 Sesquiterpene lactones ..........................................................................................11 2.2.1 Helenalin..............................................................

Informations

Publié par
Publié le 01 janvier 2010
Nombre de lectures 55
Langue Deutsch
Poids de l'ouvrage 7 Mo

Extrait

Dissertation zur Erlangung des Doktorgrades
der Fakultät für Chemie und Pharmazie
der Ludwig-Maximilians-Universität München



Investigation of helenalin-induced cell death in Bcl-2
overexpressing Jurkat cells






Ruth Hoffmann
(geb. Meßmer)
aus Spaichingen
2010 Erklärung
Diese Dissertation wurde im Sinne von §13 Abs. 3 bzw. 4 der Promotionsordnung vom 29.
Januar 1998 von Frau Prof. Dr. Angelika M. Vollmar am Lehrstuhl für Pharmazeutische
Biologie betreut.




Ehrenwörtliche Versicherung
Diese Dissertation wurde selbstständig, ohne unerlaubte Hilfe erarbeitet.


München, am 20.09.2010




Ruth Hoffmann (geb.Meßmer)




Dissertation eingereicht am: 20.09.2010
1. Gutachter: Prof. Dr. Angelika M. Vollmar
2. Gutachter: PD Dr. Manfred Ogris
Mündliche Prüfung am: 29.10.2010 CONTENTS 5
CONTENTS 6 CONTENTS
1 CONTENTS
1 CONTENTS..............................................................................................................6
2 INTRODUCTION ....................................................................................................10
2.1 Background and aim of the study ...........................................................................10
2.2 Sesquiterpene lactones ..........................................................................................11
2.2.1 Helenalin.................................................................................................................11
2.3 Bcl-2 .......................................................................................................................13
2.3.1 The Bcl-2 family......................................................................................................13
2.3.2 Regulation of Bcl-2 by phosphorylation ..................................................................13
2.4 Cell death ...............................................................................................................14
2.5 Apoptosis................................................................................................................14
2.6 Necrosis..................................................................................................................16
2.7 Autophagy ..............................................................................................................18
2.7.1 Crosstalk between apoptosis and autophagy.........................................................19
2.8 ER stress and autophagy .......................................................................................19
2.8.1 ER stress19
2.8.2 ER stress - autophagy link......................................................................................20
2.9 Mechanism how Bcl-2 protects from cell death ......................................................21
2.9.1 Bcl-2-mediated regulation of mitochondrial membrane permeabilization...............21
2.9.2 n of calcium flux in the ER ...............................................22
2.10 Significance to overcome Bcl-2-mediated resistance.............................................24
2.10.1 Bcl-2 inhibitors in cancer therapy ...........................................................................24
2.10.2 Overcoming cell death resistance by Bcl-2 overexpression using helenalin ..........25
3 MATERIALS AND METHODS...............................................................................28
3.1 Materials .................................................................................................................28
3.1.1 Biochemicals, inhibitors, dyes, buffers and cell culture reagents ...........................28
3.1.2 Technical equipment ..............................................................................................30
3.2 Cell Culture.............................................................................................................30
3.2.1 Cell lines30
3.2.2 Cell culture..............................................................................................................31
3.2.3 Seeding for experiments.........................................................................................32
3.2.4 Freezing and thawing .............................................................................................32
3.3 Flow cytometry .......................................................................................................32
3.3.1 Quantification of Cell death ....................................................................................33
3.3.1.1 Nicoletti assay ........................................................................................................33
3.3.1.2 PI exclusion assay..................................................................................................33 CONTENTS 7
3.3.1.3 Annexin-V/PI double staining .................................................................................33
3.3.2 Measurement of ROS generation...........................................................................34
3.3.3 nt of mitochondrial potential dissipitation.............................................34
3.4 Clonogenic assay ...................................................................................................34
3.5 Western blot ...........................................................................................................35
3.5.1 Whole lysate preparation........................................................................................35
3.5.2 Preparation of cytosolic and mitochondrial fractions ..............................................36
3.5.3 Immunoprecipitation ...............................................................................................36
3.5.4 Protein quantification ..............................................................................................37
3.5.5 SDS-PAGE .............................................................................................................37
3.5.6 Tank electroblotting ................................................................................................38
3.5.7 Protein detection.....................................................................................................39
3.5.7.1 Enhanced chemiluminescence...............................................................................40
3.5.7.2 Infrared imaging......................................................................................................40
3.5.8 Staining of gels and membranes ............................................................................41
3.6 Transfection of cells41
3.6.1 with Apaf-1 and AIF siRNA ................................................................41
3.6.2 Transfection with plasmids .....................................................................................41
3.7 Reporter gene assay ..............................................................................................41
3.8 Electrophoretic mobility shift assay (EMSA)...........................................................42
3.8.1 Praparation of nuclear extracts...............................................................................42
3.8.2 Binding reaction and electrophoretic separation ....................................................43
3.9 Caspase activity assay ...........................................................................................44
3.10 Calcium measurement............................................................................................45
3.11 Transmission Electron Microscopy.........................................................................45
3.12 Statistical Analysis..................................................................................................45
4 RESULTS...............................................................................................................48
4.1 Helenalin overcomes Bcl-2-mediated resistance....................................................48
4.2 Helenalin does not abrogate mitochondrial function of Bcl-2 and acts
independently of the mitochondria and the apoptosome........................................51
4.2.1 Mitochondrial function.............................................................................................51
4.2.2 Caspase dependency54
4.3 Mechanisms of helenalin’s bypass of Bcl-2-mediated cytoprotection.....................58
4.3.1 ER stress, autophagy and necroptosis...................................................................58
4.3.2 Helenalin inhibits Bcl-2-induced NF- κB activity ......................................................63
4.3.3 duces cell death by induction of ROS..................................................66 8 CONTENTS
5 DISCUSSION .........................................................................................................70
5.1 Untypical signaling of helenalin-induced cell death ................................................70
5.1.1 Apoptosis................................................................................................................70
5.1.2 Autophagy .....................................

  • Univers Univers
  • Ebooks Ebooks
  • Livres audio Livres audio
  • Presse Presse
  • Podcasts Podcasts
  • BD BD
  • Documents Documents